GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elixinol Wellness Ltd (ASX:EXL) » Definitions » LT-Debt-to-Total-Asset

Elixinol Wellness (ASX:EXL) LT-Debt-to-Total-Asset : 0.02 (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Elixinol Wellness LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Elixinol Wellness's long-term debt to total assests ratio for the quarter that ended in Dec. 2023 was 0.02.

Elixinol Wellness's long-term debt to total assets ratio declined from Dec. 2022 (0.07) to Dec. 2023 (0.02). It may suggest that Elixinol Wellness is progressively becoming less dependent on debt to grow their business.


Elixinol Wellness LT-Debt-to-Total-Asset Historical Data

The historical data trend for Elixinol Wellness's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elixinol Wellness LT-Debt-to-Total-Asset Chart

Elixinol Wellness Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial 0.03 0.04 0.06 0.07 0.02

Elixinol Wellness Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.07 0.07 0.04 0.02

Elixinol Wellness LT-Debt-to-Total-Asset Calculation

Elixinol Wellness's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )/Total Assets (A: Dec. 2023 )
=0.192/11.711
=0.02

Elixinol Wellness's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (Q: Dec. 2023 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2023 )/Total Assets (Q: Dec. 2023 )
=0.192/11.711
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Elixinol Wellness  (ASX:EXL) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Elixinol Wellness LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Elixinol Wellness's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Elixinol Wellness (ASX:EXL) Business Description

Traded in Other Exchanges
Address
680 George Street, Level 12, Sydney, NSW, AUS, 2000
Elixinol Wellness Ltd is engaged in the hemp industry, innovating, marketing, and selling hemp-derived nutraceutical, cosmetic, and food products. It operates in the geographical segments of the Americas, Australia, Europe and other regions of which key revenue is derived from the Americas segment. The Americas segment includes the trading results of Elixinol LLC (Elixinol Americas) and its investments and joint ventures in the US through the manufacture and distribution of hemp-derived cannabidiol products.

Elixinol Wellness (ASX:EXL) Headlines

No Headlines